BioCentury | Jan 12, 2018
Clinical News

Merck reports Phase II data for Keytruda in breast cancer

...The trial was sponsored by the International Breast Cancer Study Group in collaboration with the Breast International Group...
BioCentury | Sep 5, 2016
Clinical News

MammaPrint: Phase III data

...a collaboration between Agendia, the European Organization for Research and Treatment of Cancer (EORTC) and Breast International Group (BIG)...
BioCentury | Sep 14, 2015
Clinical News

Ibrance palbociclib: Phase III started

...the Alliance Foundation Trials LLC, the Austrian Breast & Colorectal Cancer Study Group (ABCSG), the Breast International Group...
BioCentury | Jun 9, 2014
Clinical News

Herceptin trastuzumab: Phase III data

...and conducted in collaboration with NIH's NCI, the North Central Cancer Treatment Group and the Breast International Group...
BioCentury | Jun 9, 2014
Clinical News

Tykerb: Phase III data

...and conducted in collaboration with NIH's NCI, the North Central Cancer Treatment Group and the Breast International Group...
BioCentury | Jun 3, 2014
Clinical News

Adjuvant Tykerb, Herceptin miss in Phase III ALTTO trial

...collaboration with NIH's National Cancer Institute , the North Central Cancer Treatment Group and the Breast International Group...
BioCentury | Jul 1, 2013
Company News

Myriad Genetics, Tesaro deal

...Netherlands) to facilitate the ovarian cancer trial, while the breast cancer trial is partnered with Breast International Group (BIG)...
BioCentury | Jun 10, 2013
Company News

Tesaro, Breast International Group (BIG), European Network of Gynecological Oncological Trial Groups (ENGOT), European Organization for Research and Treatment o

...deal (see BioCentury, June 11, 2012 & May 20, 2013). Tesaro Inc. (NASDAQ:TSRO), Waltham, Mass. Breast International Group (BIG)...
BioCentury | Oct 15, 2012
Clinical News

Herceptin trastuzumab: Final Phase III data

...and cardiac safety Status: Final Phase III data Milestone: NA Roche and researchers at the Breast International Group...
BioCentury | Oct 24, 2011
Clinical News

MammaPrint: Completed Phase III enrollment

...Agendia and the European Organization for Research and Treatment of Cancer (EORTC) and Breast International Group (BIG) completed enrollment...
Items per page:
1 - 10 of 16
BioCentury | Jan 12, 2018
Clinical News

Merck reports Phase II data for Keytruda in breast cancer

...The trial was sponsored by the International Breast Cancer Study Group in collaboration with the Breast International Group...
BioCentury | Sep 5, 2016
Clinical News

MammaPrint: Phase III data

...a collaboration between Agendia, the European Organization for Research and Treatment of Cancer (EORTC) and Breast International Group (BIG)...
BioCentury | Sep 14, 2015
Clinical News

Ibrance palbociclib: Phase III started

...the Alliance Foundation Trials LLC, the Austrian Breast & Colorectal Cancer Study Group (ABCSG), the Breast International Group...
BioCentury | Jun 9, 2014
Clinical News

Herceptin trastuzumab: Phase III data

...and conducted in collaboration with NIH's NCI, the North Central Cancer Treatment Group and the Breast International Group...
BioCentury | Jun 9, 2014
Clinical News

Tykerb: Phase III data

...and conducted in collaboration with NIH's NCI, the North Central Cancer Treatment Group and the Breast International Group...
BioCentury | Jun 3, 2014
Clinical News

Adjuvant Tykerb, Herceptin miss in Phase III ALTTO trial

...collaboration with NIH's National Cancer Institute , the North Central Cancer Treatment Group and the Breast International Group...
BioCentury | Jul 1, 2013
Company News

Myriad Genetics, Tesaro deal

...Netherlands) to facilitate the ovarian cancer trial, while the breast cancer trial is partnered with Breast International Group (BIG)...
BioCentury | Jun 10, 2013
Company News

Tesaro, Breast International Group (BIG), European Network of Gynecological Oncological Trial Groups (ENGOT), European Organization for Research and Treatment o

...deal (see BioCentury, June 11, 2012 & May 20, 2013). Tesaro Inc. (NASDAQ:TSRO), Waltham, Mass. Breast International Group (BIG)...
BioCentury | Oct 15, 2012
Clinical News

Herceptin trastuzumab: Final Phase III data

...and cardiac safety Status: Final Phase III data Milestone: NA Roche and researchers at the Breast International Group...
BioCentury | Oct 24, 2011
Clinical News

MammaPrint: Completed Phase III enrollment

...Agendia and the European Organization for Research and Treatment of Cancer (EORTC) and Breast International Group (BIG) completed enrollment...
Items per page:
1 - 10 of 16